The estimated Net Worth of William J. Plovanic is at least $296 ezer dollars as of 12 November 2019. Mr. Plovanic owns over 65,000 units of Obalon Therapeutics Inc stock worth over $295,853 and over the last 8 years he sold OBLN stock worth over $0. In addition, he makes $0 as Director at Obalon Therapeutics Inc.
William has made over 3 trades of the Obalon Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 65,000 units of OBLN stock worth $107,900 on 12 November 2019.
The largest trade he's ever made was buying 65,000 units of Obalon Therapeutics Inc stock on 12 November 2019 worth over $107,900. On average, William trades about 8,958 units every 51 days since 2016. As of 12 November 2019 he still owns at least 106,806 units of Obalon Therapeutics Inc stock.
You can see the complete history of Mr. Plovanic stock trades at the bottom of the page.
William J. Plovanic has been appointed as Director of the Company effective 6/29/2020. Previously, Mr. Plovanic served as Managing Director, Medical Technology Equity Research at Canaccord Genuity Inc., an investment bank, from February 2007 to March 2016. Prior to Canaccord Genuity, Mr. Plovanic served in various roles at First Albany Capital Inc. from February 2001 to February 2007, including as Managing Director, Equity Research. Mr. Plovanic holds a B.S. from Bradley University and is a CFA charterholder.
William Plovanic is 47, he's been the Director of Obalon Therapeutics Inc since 2020. There are 10 older and 2 younger executives at Obalon Therapeutics Inc. The oldest executive at Obalon Therapeutics Inc is Raymond Dittamore, 73, who is the Independent Director.
William's mailing address filed with the SEC is 5421 Avenida Encinas f, Carlsbad, CA 92008, USA.
Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma... és David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.
Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: